Clinical Trials in North Carolina

Showing 9801-9820 of 20,428 trials

Safety and Tolerability of SYNB1934 in Healthy Adult Volunteers

NCT04984525

This Phase 1, first-in-human, multiple dose-escalation, randomized, double-blinded, placebo-controlled study is evaluating SYNB1934 in healthy volunteers (HV). Eligible subjects receive investigational product (IP) and undergo safety monitoring, evaluations, and subsequent follow-up after IP administration.

Healthy

Synlogic106 participantsStarted Jul 2021

High Point, North Carolina, United States

COMPLETEDNA41 miles

Multicenter Selective Lymphadenectomy Trial II (MSLT-II)

NCT00297895

Subjects must be diagnosed with melanoma. All subjects receive sentinel lymphadenectomy. If the subject is sentinel node positive and meets study requirements, the subject is randomized to receive either (1) completion lymphadenectomy (2) observation with nodal ultrasound. Subjects are then followed for 10 years.

Melanoma

Saint John's Cancer Institute1,939 participantsStarted Sep 2004

San Diego, California, United States • Santa Monica, California, United States • Colorado Springs, Colorado, United States +60 more locations

Safety and Tolerability of SYNB1934 in Healthy Adult Volunteers

Multicenter Selective Lymphadenectomy Trial II (MSLT-II)

Find Trials by Condition in North Carolina

Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine

Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS

Evaluation of the Lung Nodule Sensitivity of Stationary Chest Tomosynthesis in Patients With Known Lung Nodules

Paravertebral Block With Brachial Plexus Block for Upper Arm Arteriovenous Fistula Surgery

Struvite Stones Antibiotic Study

Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures

Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)

Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)

Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome

Bi 671800 in Asthmatic Patients on Inhaled Corticosteroids

EndoPredict® Extended Endocrine Trial (EXET)

Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib

Dehydrated Human Umbilical Cord Allograft in the Management of Diabetic Foot Ulcers

Micronized dHACM Injectable for the Treatment of Plantar Fasciitis

A Study Evaluating CPI-1205 in Patients With B-Cell Lymphomas

Evaluation of ACUVUE OASYS® 1-Day for Astigmatism Lenses Produced on a New Manufacturing Line

Shunt Tube Exposure Prevention Study

NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)